Home Cart Sign in  
Chemical Structure| 104777-68-6 Chemical Structure| 104777-68-6

Structure of plantamajoside
CAS No.: 104777-68-6

Chemical Structure| 104777-68-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Plantamajoside, a natural product isolated and purified from the herb of Plantago depressa Willd., has anti-hepatotoxic, anti-inflammatory, antinociceptive activities, improving sexual function and antioxidant activity.

Synonyms: Y0160; C10485

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of plantamajoside

CAS No. :104777-68-6
Formula : C29H36O16
M.W : 640.59
SMILES Code : O=C(O[C@@H]1[C@@H](CO)O[C@@H](OCCC2=CC=C(O)C(O)=C2)[C@H](O)[C@H]1O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)/C=C/C4=CC=C(O)C(O)=C4
Synonyms :
Y0160; C10485
MDL No. :MFCD20527298
InChI Key :KFEFLPDKISUVNR-QJEHNBJNSA-N
Pubchem ID :5281788

Safety of plantamajoside

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
4T1 mouse breast cancer cell line 31.25, 62.5, 125, 250, 500 μg/mL 0, 12, 24, 36, 48 hours To evaluate the effect of PMS on cell proliferation, results showed that PMS significantly inhibited the proliferation of 4T1 cells in a dose- and time-dependent manner BMC Cancer. 2015 Dec 16;15:965
MDA-MB-231 human breast cancer cell line 31.25, 62.5, 125, 250, 500 μg/mL 0, 12, 24, 36, 48 hours To evaluate the effect of PMS on cell proliferation, results showed that PMS significantly inhibited the proliferation of MDA-MB-231 cells in a dose- and time-dependent manner BMC Cancer. 2015 Dec 16;15:965
MIN6 cells 12.5 µM, 25 µM, 50 µM 24 hours To evaluate the protective effect of PMS on high glucose and palmitic acid-induced MIN6 cell damage. PMS intervention improved cell injury, reduced intracellular ROS levels, decreased LDH activity, and increased insulin secretion. World J Diabetes. 2025 Feb 15;16(2):99053
RSC96 cells 12.5, 25, 50 µM 24 hours To evaluate the protective effect of PMS on high glucose-induced RSC96 cell damage. Results showed that PMS enhanced cell viability and reduced LDH activity in a concentration-dependent manner. J Cell Mol Med. 2025 Apr;29(8):e70571
Chinese Hamster Ovary (CHO-K1) cells 300 μg/mL 36 hours To evaluate the side effects of PMS on normal cells, results showed that PMS had no significant effect on CHO cell viability BMC Cancer. 2015 Dec 16;15:965
H9c2 myocardial cells 5-40 µM 48 hours PMS was not cytotoxic in the concentration range of 5–40 μM and increased cell survival after H/R injury in a concentration-dependent manner without affecting proliferation or growth. BMC Complement Med Ther. 2023 Feb 24;23(1):64
HepG2/SOR cells 200 ng/mL 48 hours To evaluate the anti-cancer effect of PMS and SOR on HepG2/SOR cells. Results showed that PMS significantly enhanced the cytotoxicity of SOR to drug-resistant HepG2/SOR cells. Drug Deliv. 2019 Dec;26(1):1080-1091
MCF-12A 400 µM 72 hours Evaluation of the cytotoxic effect of plantamajoside on MCF-12A cells, showing an IC50 value of 296.2 μM Life (Basel). 2023 Feb 16;13(2):556
HepG2 300 µM 72 hours Evaluation of the cytotoxic effect of plantamajoside on HepG2 cells, showing an IC50 value of 156.1 μM Life (Basel). 2023 Feb 16;13(2):556
U138-MG 300 µM 72 hours Evaluation of the cytotoxic effect of plantamajoside on U138-MG cells, showing an IC50 value of 266.7 μM Life (Basel). 2023 Feb 16;13(2):556
OVCAR-3 200 µM 72 hours Evaluation of the cytotoxic effect of plantamajoside on OVCAR-3 cells, showing an IC50 value of 138.9 μM Life (Basel). 2023 Feb 16;13(2):556
MDA-MB-231 300 µM 72 hours Evaluation of the cytotoxic effect of plantamajoside on MDA-MB-231 cells, showing an IC50 value of 263.1 μM Life (Basel). 2023 Feb 16;13(2):556
MCF-7 300 µM 72 hours Evaluation of the cytotoxic effect of plantamajoside on MCF-7 cells, showing an IC50 value of 170.8 μM Life (Basel). 2023 Feb 16;13(2):556

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague Dawley rats High-fat diet-induced NAFLD model Intraperitoneal injection 20, 40, 80 mg/kg Once daily for 4 weeks PMS alleviated liver damage, improved immune dysregulation and abnormal hepatic lipid metabolism in HFD-induced NAFLD rats by activating the AMPK/Nrf2 pathway Kaohsiung J Med Sci. 2023 Aug;39(8):801-810
BALB/c mice 4T1 cell-induced allograft mammary tumor model Oral administration 200 mg/kg Once daily for 21 consecutive days To evaluate the effect of PMS on tumor growth and pulmonary metastasis in vivo, results showed that PMS significantly reduced allograft tumor volume and weights, significantly decreased microvascular density and significantly lowered lung metastasis rate BMC Cancer. 2015 Dec 16;15:965
C57BL/6 male mice Acute sepsis model induced by cecal ligation and puncture (CLP) Intraperitoneal injection 25, 50, 100 mg PMS/kg Assessed within 24 hours after modeling and treatment PMS alleviated sepsis-induced organ dysfunction by inhibiting the TRAF6/NF-κB axis, improved survival rates, reduced lung, liver, and heart injuries, and suppressed inflammatory responses and apoptosis Pharm Biol. 2023 Dec;61(1):897-906
C57BL/6 mice Diabetic peripheral neuropathy (DPN) model Oral 25, 50, 100 mg/kg Once daily for 4 weeks To evaluate the therapeutic effect of PMS on DPN mice. Results showed that PMS improved mechanical pain threshold, thermal pain reaction time, and nerve conduction velocity, and reduced pathological damage to the sciatic nerve. J Cell Mol Med. 2025 Apr;29(8):e70571
Spontaneously hypertensive rats (SHR) Spontaneously hypertensive rat model Oral 400 mg/kg Once daily for 12 weeks To investigate the antihypertensive effect and underlying mechanisms of PASE in SHR. Results showed PASE significantly lowered blood pressure and improved cardiac and aortic indices and collagen accumulation. Front Pharmacol. 2019 Apr 30;10:403
C57BL/6 mice Type 2 diabetes model Oral gavage 50 mg/kg and 100 mg/kg Once daily for 4 weeks To evaluate the therapeutic effects of PMS on type 2 diabetes mice. PMS intervention significantly improved body weight, fasting blood glucose, and glycated serum protein levels, and alleviated pancreatic tissue damage. World J Diabetes. 2025 Feb 15;16(2):99053

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.56mL

0.31mL

0.16mL

7.81mL

1.56mL

0.78mL

15.61mL

3.12mL

1.56mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories